Your browser doesn't support javascript.
loading
Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation / 대한간학회지
The Korean Journal of Hepatology ; : 131-139, 2009.
Article in Korean | WPRIM | ID: wpr-111399
ABSTRACT
BACKGROUND/

AIMS:

This study examined the effects of hepatitis B virus (HBV) infection state and immunologic capability in both the recipients and donors of allogenic hematopoietic stem-cell transplantation (allo-HSCT) on changes in HBV serologic markers in recipients.

METHODS:

A total of 537 patients underwent allo-HSCT for the treatment of leukemia, malignant lymphoma, and solid tumor. HBV serologic markers were examined in both recipients and donors prior to and following the transplantation. The mean follow-up period was 36.6 months (range 3-80 months).

RESULTS:

Of the 537 patients who underwent allo-HSCT, 45 recipients were positive for HBsAg prior to transplantation. Of these 45 patients, 21 were transplanted from anti-HBs-positive donors and the remaining 24 were transplanted from anti-HBs-negative donors. In the former cases, seroconversion was noted in 4 of the 21 patients (19%). In the latter cases, however, no seroconversion was noted following the transplantation. Thirty patients who were negative for both HBsAg and anti-HBs were transplanted from anti-HBs-positive donors, and 15 out of 30 patients (50%) acquired anti-HBs. Four hundred and seven patients who were positive for anti-HBs were transplanted from anti-HBs-positive or HbsAg-negative donors; 8 of these proved HBsAg-positive following the transplantation. There were no changes in HBV serological markers following transplantation in 41 patients who were transplanted from HbsAg-positive donors.

CONCLUSIONS:

Due to the adoptive immunity that was transferred from anti-HBs-positive donors, a seroconversion of HBsAg could occur in some HBsAg-positive recipients. HBsAg-positive donors had a lesser effect on the HBV serologic markers of recipients. However, a reactivation of HBV can occur following hematopoietic stem-cell transplantation in the cases of recipients or donors with a history of HBV, infection by an accompanying immune suppression. Therefore, prevention should be instigated.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Tissue Donors / Transplantation, Homologous / Virus Activation / Biomarkers / Retrospective Studies / Hematopoietic Stem Cell Transplantation / Hepatitis B / Hepatitis B Antibodies / Hepatitis B Surface Antigens Type of study: Observational study Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: Korean Journal: The Korean Journal of Hepatology Year: 2009 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Tissue Donors / Transplantation, Homologous / Virus Activation / Biomarkers / Retrospective Studies / Hematopoietic Stem Cell Transplantation / Hepatitis B / Hepatitis B Antibodies / Hepatitis B Surface Antigens Type of study: Observational study Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: Korean Journal: The Korean Journal of Hepatology Year: 2009 Type: Article